Articles by Disease (Non-melanoma Skin Cancer)

Genetic Idiotypic and Tumor Cell-Based Vaccine Strategies for Indolent Non Hodgkins Lymphoma

Journal: Current Gene Therapy
Volume: 5
Page: 511-521
Author(s): Pier A. Ruffini, Massimo Di Nicola, Carmelo Carlo-Stella, Salvatore Siena and Alessandro M. Gianni

Immune Response to Herpes Simplex Virus and γ134.5 Deleted HSV Vectors

Journal: Current Gene Therapy
Volume: 5
Page: 523-530
Author(s): Eeva K. Broberg and Veijo Hukkanen

Melanoma Immunotherapy: Past, Present, and Future

Journal: Current Pharmaceutical Design
Volume: 11
Page: 3461-3473
Author(s): F. Saleh, W. Renno, I. Klepacek, G. Ibrahim, S. Asfar, H. Dashti, P. Romero, A. Dashti and A. Behbehani

Therapeutic Vaccines for Cervical Cancer: Dendritic Cell-Based Immunotherapy

Journal: Current Pharmaceutical Design
Volume: 11
Page: 3485-3500
Author(s): A. D. Santin, S. Bellone, J. J. Roman, A. Burnett, M. J. Cannon and S. Pecorelli

Immunity to Tumour Antigens

Journal: Current Pharmaceutical Design
Volume: 11
Page: 3501-3509
Author(s): G. Li, S. A. Ali, S. E.B. McArdle, S. Mian, M. Ahmad, A. Miles and R. C. Rees

Use of Cytokines in Cancer Vaccines/Immunotherapy: Recent Developments Improve Survival Rates for Patients with Metastatic Malignancy

Journal: Current Pharmaceutical Design
Volume: 11
Page: 3511-3530
Author(s): S. Dezfouli, I. Hatzinisiriou and S. J. Ralph

Direct Evidence on the Immune-Mediated Spontaneous Regression of Human Cancer: An Incentive for Pharmaceutical Companies to Develop a Novel Anti-Cancer Vaccine

Journal: Current Pharmaceutical Design
Volume: 11
Page: 3531-3543
Author(s): F. Saleh, I. Klepacek, G. Ibrahim, H. Dashti, S. Asfar, A. Behbehani, H. Al-Sayer and A. Dashti